Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    SNCA
Show Display Options
RSS Create an RSS feed from your search for:
SNCA
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Oligomeric Alpha-synuclein in Multiple System Atrophy
Condition: Multiple System Atrophy (MSA)
Intervention:
2 Active, not recruiting Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain
Condition: Parkinson's Disease
Intervention: Drug: Glycerol Phenylbutyrate
3 Unknown  Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.
Condition: "Alzheimer's Disease" and "Lewy Body Disease"
Interventions: Other: MRI;   Procedure: lumbar puncture;   Behavioral: neuropsychological tests
4 Active, not recruiting Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
Conditions: Parkinson Disease;   Parkinsonian Disorders
Intervention: Procedure: Biopsy of skin
5 Recruiting Biomarkers in Parkinsonian Syndromes
Conditions: Parkinsonian Syndromes;   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
Interventions: Other: CSF, blood and urine sampling;   Other: clinical measures of disease severity and progression
6 Completed Analysis of the Enteric Nervous System Using Colonic Biopsies
Conditions: Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
Intervention: Procedure: colonoscopy or rectosigmoidoscopy
7 Completed GALIG Gene Expression in Parkinson's Disease
Condition: Parkinson Disease
Intervention: Other: Blood sampling
8 Unknown  Diagnostic and Prognostic Biomarkers in Parkinson Disease
Conditions: Parkinson Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
Intervention:
9 Recruiting Systemic Synuclein Sampling Study (S4)
Condition: Parkinson's Disease
Interventions: Procedure: Biofluid samplings;   Procedure: Tissue samplings;   Drug: DaTSCAN™
10 Terminated Early Parkinson's Disease (PD) Cross-Sectional
Condition: Parkinson's Disease
Intervention:
11 Withdrawn Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients
Condition: Parkinson's Disease
Interventions: Biological: AFFITOPE® PD01A + Adjuvant;   Biological: Adjuvant without active component
12 Recruiting Natural History Study of Synucleinopathies
Condition: Patients With Synucleinopathies
Intervention:
13 Not yet recruiting Enteric Nervous System in Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Procedure: Rectosigmoidoscopy with colonic biopsies;   Procedure: Colonoscopy with colonic biopsies
14 Terminated Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation
Condition: Parkinson's Disease
Intervention: Other: colonoscopy or rectosigmoidoscopy
15 Not yet recruiting Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease
Conditions: Parkinson Disease;   Parkinsons Disease With Dementia
Interventions: Drug: Placebo Oral Capsule;   Drug: Nilotinib 150mg oral capsule [Tasigna];   Drug: Nilotinib 300mg oral capsule [Tasigna]
16 Completed Biological Markers in Parkinson's Disease
Condition: Parkinson Disease
Intervention:
17 Recruiting Ambroxol as a Treatment for Parkinson's Disease Dementia
Condition: Parkinson's Disease Dementia
Interventions: Drug: Ambroxol;   Other: Placebo
18 Active, not recruiting Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment
Condition: Autonomic Disturbances in Parkinson`s Disease
Interventions: Drug: Pyridostigmine bromide;   Drug: fludrocortisone
19 Unknown  Clinical, Molecular and by Neuroimaging of LRRK2 Mutations
Condition: Parkinson's Disease
Intervention:
20 Active, not recruiting Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
Conditions: Parkinson's Disease;   HIV Infections
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.